Product
Havrix
2 clinical trials
2 indications
Indication
Hepatitis A VaccineIndication
COVID-19Clinical trial
A Randomized, Double-blind, Multi-center, Active-controlled, Parallel-designed, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Korean Healthy Children Aged 12~23 MonthsStatus: Completed, Estimated PCD: 2019-06-24
Clinical trial
A Double-Blind, Randomized, Controlled, Phase 3 Study to Evaluate the Safety and Immunogenicity of CpG 1018/Alum-adjuvanted SCB-2019 in Individuals Aged 18 and Above With Chronic Immune-Mediated Inflammatory DiseasesStatus: Terminated, Estimated PCD: 2022-03-30